Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 120

1.

Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study).

Comyn O, Wickham L, Charteris DG, Sullivan PM, Ezra E, Gregor Z, Aylward GW, da Cruz L, Fabinyi D, Peto T, Restori M, Xing W, Bunce C, Hykin PG, Bainbridge JW.

Eye (Lond). 2017 May 12. doi: 10.1038/eye.2017.75. [Epub ahead of print]

PMID:
28498374
2.

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.

Sivaprasad S, Prevost AT, Vasconcelos JC, Riddell A, Murphy C, Kelly J, Bainbridge J, Tudor-Edwards R, Hopkins D, Hykin P; CLARITY Study Group..

Lancet. 2017 May 5. pii: S0140-6736(17)31193-5. doi: 10.1016/S0140-6736(17)31193-5. [Epub ahead of print]

3.

Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.

Nicholson L, Patrao NV, Ramu J, Vazquez-Alfageme C, Muwas M, Rajendram R, Hykin PG, Sivaprasad S.

Eye (Lond). 2017 Apr 28. doi: 10.1038/eye.2017.69. [Epub ahead of print]

PMID:
28452992
4.

Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema.

Ramu J, Chatziralli I, Yang Y, Menon G, Bailey C, Eckstein M, Hykin P, Sivaprasad S.

Patient Prefer Adherence. 2017 Mar 17;11:579-586. doi: 10.2147/PPA.S132859. eCollection 2017.

5.

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Nilsson J, Kim K, Sivaprasad S.

Eye (Lond). 2017 Jan;31(1):166. doi: 10.1038/eye.2016.276. No abstract available.

6.

Reply.

Eleftheriadou M, Vazquez-Alfageme C, Citu CM, Crosby-Nwaobi R, Sivaprasad S, Hykin P, Hamilton RD, Patel PJ.

Am J Ophthalmol. 2017 Feb;174:186. doi: 10.1016/j.ajo.2016.12.004. Epub 2016 Dec 23. No abstract available.

PMID:
28024646
7.

Reply.

Patrao NV, Antao S, Egan C, Omar A, Hamilton R, Hykin PG, Sivaprasad S, Rajendram R; Moorfields Diabetic Macular Edema Study Group..

Am J Ophthalmol. 2017 Feb;174:176. doi: 10.1016/j.ajo.2016.10.016. Epub 2016 Nov 30. No abstract available.

PMID:
27914628
8.

Identifying Predictors of Anti-VEGF Treatment Response in Patients with Neovascular Age-Related Macular Degeneration through Discriminant and Principal Component Analysis.

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Hoyng CB, Wittrup-Jensen K, Altemark A, Nilsson J, Kim K, Sivaprasad S.

Ophthalmic Res. 2016 Nov 11. [Epub ahead of print]

PMID:
27832661
9.

Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting.

Eleftheriadou M, Vazquez-Alfageme C, Citu CM, Crosby-Nwaobi R, Sivaprasad S, Hykin P, Hamilton RD, Patel PJ.

Am J Ophthalmol. 2017 Feb;174:160-168. doi: 10.1016/j.ajo.2016.09.038. Epub 2016 Oct 14.

PMID:
27746298
10.

Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.

Patrao NV, Antao S, Egan C, Omar A, Hamilton R, Hykin PG, Sivaprasad S, Rajendram R; Moorfields Diabetic Macular Edema Study Group..

Am J Ophthalmol. 2016 Dec;172:51-57. doi: 10.1016/j.ajo.2016.09.002. Epub 2016 Sep 13.

PMID:
27637784
11.

Posterior Segment Distortion in Ultra-Widefield Imaging Compared to Conventional Modalities.

Nicholson L, Goh LY, Marshall E, Vazquez-Alfageme C, Chatziralli I, Clemo M, Hykin PG, Sivaprasad S.

Ophthalmic Surg Lasers Imaging Retina. 2016 Jul 1;47(7):644-51. doi: 10.3928/23258160-20160707-06.

PMID:
27434896
12.

Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting.

Gohil R, Crosby-Nwaobi R, Forbes A, Burton BJ, Hykin P, Sivaprasad S.

Patient Prefer Adherence. 2016 May 26;10:949-55. doi: 10.2147/PPA.S105536. eCollection 2016.

13.

Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept.

Chatziralli I, Nicholson L, Vrizidou E, Koutsiouki C, Menon D, Sergentanis TN, Citu MC, Hamilton R, Patel PJ, Hykin P, Sivaprasad S.

Ophthalmology. 2016 Aug;123(8):1762-70. doi: 10.1016/j.ophtha.2016.05.002. Epub 2016 Jun 9.

PMID:
27289179
14.

An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases.

Crosby-Nwaobi R, Hykin P, Peto T, Sivaprasad S.

Clin Ophthalmol. 2016 May 11;10:835-44. doi: 10.2147/OPTH.S102798. eCollection 2016.

15.

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Nilsson J, Kim K, Sivaprasad S.

Eye (Lond). 2016 Aug;30(8):1063-71. doi: 10.1038/eye.2016.90. Epub 2016 May 20.

16.

The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary.

Sivaprasad S, Amoaku WM, Hykin P, Guideline Group RV.

Eye (Lond). 2016 Apr;30(4):642. doi: 10.1038/eye.2016.16. No abstract available.

17.

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study.

Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Altemark A, Nilsson J, Kim K, Sivaprasad S.

Br J Ophthalmol. 2016 Dec;100(12):1623-1628. doi: 10.1136/bjophthalmol-2015-308166. Epub 2016 Mar 30.

18.

Perspectives on reticular pseudodrusen in age-related macular degeneration.

Sivaprasad S, Bird A, Nitiahpapand R, Nicholson L, Hykin P, Chatziralli I; Moorfields UCL AMD Consortium..

Surv Ophthalmol. 2016 Sep-Oct;61(5):521-37. doi: 10.1016/j.survophthal.2016.02.005. Epub 2016 Mar 17. Review.

PMID:
26994868
19.

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK.

Hykin P, Chakravarthy U, Lotery A, McKibbin M, Napier J, Sivaprasad S.

Clin Ophthalmol. 2016 Jan 13;10:87-96. doi: 10.2147/OPTH.S92627. eCollection 2016.

20.

The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary.

Sivaprasad S, Amoaku WM, Hykin P; RVO Guideline Group..

Eye (Lond). 2015 Dec;29(12):1640. doi: 10.1038/eye.2015.237. No abstract available.

Supplemental Content

Loading ...
Support Center